baber/WOPTO huggingface dataset:
Patent EP-1091392-A2 (EP)
Inventor: HUANG CHIN-YI
IPC: H01L29/423
Filed: 2000-10-04
Abstract: This invention includes a floating gate having a first and second end region,
each of which are positioned adjacent to a corresponding lateral end of the floating
gate. A middle region is positioned laterally towards a middle of the floating gate
relative to the first and second end regions. The first end region, the middle region
and the second end region are formed of a same material during a single fabrication
step, and the middle region formed has a thickness which is less than a thickness of
the first or second end regions. This invention further includes a method for forming
a contoured floating gate for use in a floating gate memory cell. The method includes
forming a polysilicon layer over first and second spaced apart oxide structures and a
floating gate region between the first and second oxide structures such that the
polysilicon layer formed in the floating gate region has a first end region adjacent the
first oxide structure, a second end region adjacent the second oxide structure, and a
middle region positioned laterally between the first and second end regions. The
method further includes removing a portion of the polysilicon layer in the floating
gate region such that the vertical thickness of the first and second end regions remain
greater than the vertical thickness of the middle region.
Patent EP-1151631-A2 (EP)
Inventor: BANK GRAHAM
IPC: H04R7/04
Filed: 2000-02-09
Abstract: L'invention concerne une excitatrice pour exciter des ondes de flexion. Cette excitatrice comprend une bobine mobile (5), un ensemble formant aimant (11) avec des ouvertures (21) et un étai (23) comportant des nervures (27) s'étendant dans les ouvertures (21) pour coupler les plinthes du haut à celles du bas (1,3)
Patent EP-1165811-A2 (EP)
Inventor: LEWANDOWSKI DENNIS J
IPC: C12N15/82
Filed: 2000-03-08
Abstract: L'invention concerne un système de vecteurs ARN à composants multiples, constitué de réplicons à ARN dérivés de virus d'ARN et de virus auxiliaires. Elle concerne également un procédé de production d'ARN étrangers, d'ARN effecteurs, de protéines ou de peptides dans des plantes utilisant le système de vecteurs ARN à composants multiples. De plus, elle traite d'un procédé de production stable et systémique d'ARN étrangers, d'ARN effecteurs, de protéines et de peptides au moyen dudit système.
Patent EP-1190351-A2 (EP)
Inventor: NEELAY DINESH
IPC: G06Q10/04
Filed: 2000-03-15
Abstract: L'invention porte sur un système de distribution (100) par lots qui maximalise la quantité de matériau à transférer d'une source (101) à une destination (110) en déterminant si un premier total et/ou un deuxième total enregistrés par un débitmètre (103) ont atteint un premier objectif et/ou un deuxième objectif. Dans l'une des exécutions, le premier et le deuxième objectif sont des masses, des volumes et/ou des solides nets.
Patent EP-1210419-A2 (EP)
Inventor: YUE HENRY
IPC: A61P37/02
Filed: 2000-03-22
Abstract: L'invention concerne des protéines transmembranaires humaines (HTMP) et des polynucléotides qui identifient et codent pour HTMP; des vecteurs d'expression, des cellules hôtes, des anticorps, des agonistes et des antagonistes; et des méthodes permettant de diagnostiquer, de traiter ou de prévenir les troubles associés à l'expression de HTMP.
Patent EP-1171586-A2 (EP)
Title: Procedes et compositions pour l'inhibition de la fonction de sequences polynucleotidiques
Inventor: PACHUK CATHERINE
IPC: C12N15/09
Filed: 2000-04-19
Abstract: La présente invention concerne une composition thérapeutique pour l'inhibition de la fonction d'une séquence polynucléotidique cible dans une cellule mammalienne comprenant un agent qui fournit à la cellule mammalienne une molécule d'ARN à double brin au moins en partie comprenant une séquence polynucléotidique d'une longueur d'au moins 200 nucléotides, ladite séquence polynucléotidique étant sensiblement homologue à la séquence polynucléotidique cible. Avantageusement cette molécule d'ARN ne produit pas une protéine fonctionnelle. Les agents utilisés dans cette composition peuvent être des molécules d'ARN produites par des procédés de synthèse enzymatique ou des procédés de synthèse chimique in vitro; ou produites dans des cultures recombinantes de micro-organismes et d'où elles sont isolées, ou alternativement, pouvant générer la molécule d'ARN désirée in vivo après sa délivrance dans la cellule mammalienne. Dans les méthodes de traitement prophylactiques des infections virales, d'autres infections pathogènes ou de certains cancers, lesdites compositions sont administrées an quantités efficaces pour réduire ou inhiber la fonction de la séquence polynucléotidique cible, qui peut être d'origine pathogène ou produite en réaction à une tumeur ou tout autre cancer, entre autres sources.
Patent EP-1208548-A2 (EP)
Inventor: BEART PILGRIM
IPC: G08B23/00
Filed: 2000-07-26
Abstract: La présente invention concerne un système de sécurité comprenant plusieurs unités (2, 4, 6), chacune comportant un source d'énergie, un processeur (U1), un émetteur (TX1) et un récepteur (U2), et dans lequel au moins une des unités possède une alarme (H). Les unités (2, 4, 6) peuvent communiquer les unes avec les autres par le biais des émetteurs (TX1) et des récepteurs (U2), et le processeur (U1) permet de produire un signal d'alarme au cas où se produisent certains événements de communication.
Patent EP-1204428-A2 (EP)
Inventor: BAKER TERENCE SEWARD
IPC: C07C271/22
Filed: 2000-08-16
Abstract: L'invention concerne des lipides et des particules lipidiques cibles constituant des ensembles de lipides multipolaires, de molécules de ciblage comme les anticorps et de polyanions. Les lipides sont utilisés, en particulier, dans l'administration de substances bioactives, par exemple des acides nucléiques, à des cellules in vitro et particulièrement in vivo.
Patent EP-1397577-A2 (EP)
Inventor: STEPHENS MICHAEL
IPC: C09K8/473
Filed: 2000-07-12
Abstract: L'invention concerne des compositions améliorées de suspension épaisse de ciment pour puits, qu'on obtient par addition d'un additif inhibant les fluides libres sur un mélange contenant un ciment hydraulique et de l'eau. Des inhibiteurs de fluides libres appropriés sont par exemple des polymères d'hydroxyéthylcellulose présentant une valeur cps se situant entre environ 5000 et environ 50000.
Patent EP-1212425-A2 (EP)
Inventor: BRUESSOW HARALD
IPC: C12N15/31
Filed: 2000-08-08
Abstract: La présente invention concerne une bactérie S thermophilus, qui est résistante à l'attaque d'au moins un bactériophage, un procédé de production de ladite bactérie et une composition qui comprend ladite bactérie. Ladite bactérie comprend une modification du prophage Sfi21 ou du génome bactérien qui interrompt l'expression d'un gène qui est essentiel à un bactériophage, mais qui ne l'est pas auxdites bactéries.
Patent EP-1265582-A2 (EP)
Inventor: RUBEN STEVEN M
IPC: C12Q1/68
Filed: 2000-09-28
Abstract: This invention relates to newly identified colon or colon cancer related polynucleotides and the polypeptides encoded by these polynucleotides herein collectively known as "colon cancer antigens", and the use of such colon cancer antigens for targeting specific cell types and/or diagnosing, detecting, preventing and treating disorders of the colon, particularly the presence of colon cancer and colon cancer metastases. This invention relates to colon cancer antigens as well as vectors, host cells, antibodies directed to colon cancer antigens and the recombinant or synthetic methods for producing the same. Also provided are diagnostic methods for diagnosing and treating, preventing and/or prognosing disorders related to the colon, including colon cancer, and therapeutic methods for treating such disorders. The invention further relates to screening methods for identifying agonists and antagonists of colon cancer antigens of the invention. The present invention further relates to inhibiting the production and function of the polypeptides of the present invention.
Patent EP-1245035-A2 (EP)
Inventor: ZYBURA ANDRZEJ
IPC: C23C14/34
Filed: 2000-11-29
Abstract: A microwave device with a secondary yield coefficient of less than 1 is produced by applying a coating of yttrium-iron-garnet to the inner surface of the device by sputtering.
Patent EP-1245054-A2 (EP)
Inventor: BOEHM GUSTAV
IPC: H01M8/04
Filed: 2000-12-04
Abstract: The present invention relates to improving the overall efficiency of a fuel cell system by reducing parasitic power consumption. A controller is programmed to decrease oxidant stoichiometry until oxidant starvation is detected or until oxidant stoichiometry is about one. When oxidant starvation is detected, the oxidant stoichiometry is increased until oxidant starvation is no longer detected. The fuel cell system employs a sensor for detecting an operational characteristic such as voltage output, or oxygen or hydrogen concentration in the cathode exhaust stream. The controller uses the operational characteristic to calculate oxidant stoichiometry or to determine when there is oxidant starvation at the cathode.
Patent EP-1134563-A2 (EP)
Inventor: SPRICKMANN KERKERINCK STEFAN D
IPC: G01F23/24
Filed: 2001-01-16
Abstract: The oil level sensor (1) is integrated into the suction tube (2) of the oil circulation system. The sensor has two concentric electrodes (3,4) or an impedance sensor. The oil from the sump (7) flowing in the annulus (5) between the electrodes. The sensor may be a capacitive sensor with inner and outer concentric electrodes.
Patent EP-1128168-A2 (EP)
Inventor: WATANABE IZUMI
IPC: G01F1/684
Filed: 2001-02-20
Abstract: Resin members, on the surfaces of which metal films (6, 6a, 6b) are formed, are used
for; an auxiliary air passage (11a) provided in a main air passage, in which a sensor
element (2) of a physical quantity sensor such as an air flow sensor, an intake-air
temperature sensor, etc., is situated; a housing (15); and so forth; in order to decrease
both the thermal conductivity and the emissivity of those components to respective
small values, whereby the temperature increase of the sensor (2) due to both the heat
conduction and the heat radiation can be suppressed.
Patent EP-1188532-A2 (EP)
Inventor: HEINDEL JOHN F
IPC: B29D30/06
Filed: 2001-09-10
Abstract: An improved two-piece segmented mold includes a plurality of tread mold segments (46) mounted to a frustoconical seat (48) in a mold back by a T-shaped guide bar (50) inserted in a guide slot (52) formed in the seat. The segments (46) are biased to a normally closed position in abutment with adjacent segments and in abutment with a mold side plate (44).
Patent EP-1199393-A2 (EP)
IPC: D04H1/42
Filed: 2001-09-26
Abstract: In a process for increasing the hydrophobicity of microfibers in a fleece containing polyolefin, polyester or polyamide microfibers with an average diameter of 1-10 mu m, which contain 0.5-10 wt.% firmly embedded filler particles to impart hydrophobicity, the novelty is that the microfibers are produced with an average diameter at most 1.0 times that of the filler particles.
Patent EP-1191695-A2 (EP)
Inventor: SATO YUICHI
IPC: H03K19/0944
Filed: 1998-04-15
Abstract: A MOS logic circuit includes: a pass-transistor logic
circuit, including at least one first MOS transistor (1',2'), for
performing a predetermined logic operation to provide an output;
and an amplifying circuit (3'), including at least one second
MOS transistor, for enhancing a driving capability of the
output of the pass-transistor logic circuit. An absolute value
of the threshold voltage of the at least one second MOS
transistor is set larger than an absolute value of a threshold
voltage of the at least one first transistor. 
     The MOS logic circuit can thus be operated with lower power
consumption and requires only a smaller circuit area compared
to prior art logic circuits in MOS technology.
Patent EP-1190961-A2 (EP)
Inventor: STANKUS PHILIP
IPC: B65D83/04
Filed: 1998-01-09
Abstract: A pill dispenser (1) for dispensing pills has a
container (6) for holding pills. The container (6) is
closed at one end (7) and open at an opposite end. The
container (6) is slidably received in a sleeve (2). The
dispenser (1) has an outlet (19) through which a pill can
pass from the container (6) and a gate (25) for closing the
outlet (19) to prevent a pill passing through the outlet
(19). The arrangement is such that the gate (25) is opened
when the container (6) is moved in the sleeve (2) so that a
pill can pass through the open end of the container (6) to
the outlet (19) to be dispensed from the dispenser (1).
The dispenser (1) may be arranged so that one and only one
pill is dispensed at a time.
Patent EP-1190808-A2 (EP)
Inventor: AOTA KINYA
IPC: B23K101/04
Filed: 1997-03-19
Abstract: A method of manufacturing a composite body having a welded zone at which
two members (31,32) are joined by welding; comprising the steps of
     (i)   arranging said members (31,32) edge-to-edge for welding so
that said two members at the welded zone have first surfaces and have
second surfaces at the opposite side of said members from said first
surfaces,   (ii)   performing a friction stir welding process by inserting a
friction stir welding probe (50) into said members at said second
surfaces thereof, so as to unite the two members by forming, in said
friction stir welding process, a welding bead (45),   
characterised in that said bead (45) extends through said members from
said second surfaces thereof to said first surfaces thereof thereby
providing a flush and smooth join of said first surfaces, and in that
said first surfaces provide in the welded composite body an exterior
face of the body at the welded zone.
Patent EP-1235283-A2 (EP)
Inventor: KAWAMOTO SATORU
IPC: H01L41/083
Filed: 2001-11-22
Abstract: A piezoelectric actuator drive circuit (2) has an
abnormality detection circuit section (29E, 29F). The
abnormality detection circuit section (29E, 29F) is provided with
a voltage detection means (31) for detecting the voltage (Vcom)
of a connection terminal (201E, 201F) on the non-ground side and
a comparison means (32) for generating a comparison signal (Vcomp)
to check whether a detected voltage is higher than a reference
voltage (Vref) or not based on the comparison result between the
detected voltage and the reference voltage. If the detected
voltage is lower than the reference voltage, it is determined that
a cable (203A-203F) is disconnected.
Patent EP-1104068-A2 (EP)
Inventor: CARTER MICHAEL BARON
IPC: H02H3/027
Filed: 1996-11-14
Abstract: A circuit interrupter arrangement for interrupting
current in a circuit path, comprising: a current inducer
circuit; a power supply including a capacitor; a trip
command circuit for sending an electrical signal
commanding that the circuit path be interrupted by using
the voltage signal provided by the power supply; an
electrical latch actuated in response to the electrical
signal from the trip command circuit; and a control
circuit. The control circuit being responsive to said at
least one current signal provided by the current inducer
circuit, and is arranged for preventing the electrical
signal from engaging the latch until after the prescribed
minimum period of time.
Patent EP-1138943-A2 (EP)
Inventor: FRANCH GINO
IPC: F04B3/00
Filed: 2001-02-19
Abstract: The pump has devices for compensation of inertia forces transferred to the pump support frame, and to generate oscillation movements of rotors. The pump has a cylindrical curved tube, with an axis coinciding with that of the rotor to which it is fastened. The tube is divided into Nc active identical sections, so that with shut-off valves, two-phase sections with intakes and outlets are formed on opposite sides of the ring. The sum of the feed volumes of each intake is proportional to 1/Nc.
Patent EP-1139561-A2 (EP)
Inventor: IWASHITA YASUSUKE
IPC: H02P27/08
Filed: 2001-03-28
Abstract: Where high control precision is required in contour control or
the like, mode B for a short PWM period is selected to assure a high
control precision. Where high torque is required in fast feed, high
acceleration or deceleration, mode A for long PWM period is selected
so as to decrease the rate of the time of dead zone δ where voltage is
not applied to the motor.
Patent EP-1181905-A2 (EP)
Inventor: DWYER CLIFFORD J
IPC: A61F2/06
Filed: 2001-08-01
Abstract: In accordance with the present invention, there is provided a delivery
apparatus for a self-expanding stent. The apparatus has an outer sheath forming an
elongated tubular member having distal and proximal ends and an inside and outside
diameter. The apparatus also includes an inner shaft located coaxially within the
outer sheath. The inner shaft has a distal end, a proximal end and a longitudinal axis
extending therebetween. At least a portion of the inner shaft is made from a flexible
coiled member. The shaft preferably includes a stop attached thereto, the stop being
proximal to the distal end of the sheath. Lastly, the apparatus includes a self-expanding
stent located within the outer sheath, wherein the stent makes frictional
contact with the outer sheath and the shaft is disposed coaxially within a lumen of the
stent. During deployment of the stent, the stent makes contact with the stop.
Patent EP-1225665-A2 (EP)
Inventor: ZARRIS GEORGE
IPC: H04B10/291
Filed: 2001-12-12
Abstract: The present invention provides a two stage optical
fibre amplifier wherein
   the first stage of the amplifier is coupled via a
first coupler to a first pump source producing pump
radiation of a first wavelength and   the second stage of the amplifier is coupled via a
second coupler to a second pump source producing radiation
of a second wavelength  
   characterised in that
   residual pump radiation from one of the amplifier
stages is usable for amplification in the other amplifier
stage   and wherein the amplifier includes locking prevention
means for preventing radiation of the first wavelength
from reaching the second pump source and also stopping
radiation of the second wavelength from reaching the first
pump source.
Patent EP-1248840-A2 (EP)
Inventor: BALINT ROBERT F
IPC: C12N9/02
Filed: 2001-01-16
Abstract: Interaction-activated circularly permutated proteins are disclosed that depend for their functional reassembly into the parent protein on the interaction of heterologous polypeptides or other molecules which have been genetically or chemically conjugated to the break-point termini of engineered enzymes. Additionally, methods are provided for identifying circularly permutated marker proteins that will optimally reassemble into a functional parent protein, and which are dependent on the association of heterologous interactor domains. The invention is exemplified by circular permutations of a Class A β-lactamase (TEM-1 of E. coli). Circularly permutated marker proteins comprising interaction-dependent enzymes find use in (1) cell-based sensors for activation or inhibition of metabolic or signal transduction pathways, in (2) high-throughput mapping of pair-wise protein-protein interactions within and between the proteomes of cells, tissues, and pathogenic organisms, and in (3) cell-based screens for high-throughput selection of inhibitors of any protein-protein interaction.
Patent EP-1268783-A2 (EP)
Inventor: KALLURI RAGHURAM
IPC: C07K19/00
Filed: 2001-03-28
Abstract: A protein with anti-angiogenic properties is disclosed.
Patent EP-1280551-A2 (EP)
Inventor: ROVINSKI BENJAMIN
IPC: A61P31/18
Filed: 2001-04-25
Abstract: L'invention concerne un virus neutralisant le niveau des anticorps dans un isolat VIH primaire généré dans un hôte par l'administration d'antigènes donnant une première impulsion. L'antigène primaire est une molécule d'ADN codant une glycoprotéine enveloppe d'un isolat primaire de VIH-1, alors que l'antigène d'impulsion est soit une particule semblable au VIH non-répliquant, non-infectieux, possédant la glycoprotéine enveloppe d'un isolat primaire de VIH-1, soit un vecteur viral atténué, exprimant une glycoprotéine enveloppe d'un isolat primaire de VIH-1.
Patent EP-1329073-A2 (EP)
Title: Appareil et procede d'identification de paquet de donnees au debit binaire de reseau sur un port de commutation de reseau
Inventor: KRISHNA GOPAL S
IPC: H04L12/56
Filed: 2001-05-22
Abstract: L'invention concerne un commutateur de réseau configuré pour effectuer des commutations de niveau 2 et 3 dans un réseau Ethernet (IEEE 802.3) sans blocage des paquets de données entrants, comprenant un port de commutation de réseau ayant un filtre (soit un module de classification de paquets) configuré pour évaluer un paquet de données entrant de façon instantanée, immédiatement lors de sa réception au port de commutation du réseau. Ce filtre permet d'effectuer des comparaisons simultanées entre le flux de données entrant du paquet de données et plusieurs modèles configurés pour l'identification de protocoles de données respectifs. Chaque modèle est composé d'une pluralité de min-termes, chaque min-terme servant à spécifier une opération de comparaison visée dans un multiplet de données sélectionné du paquet de données entrant. Ces modèles peuvent être programmés par un utilisateur et stockés dans une mémoire de min-terme interne. Par ailleurs, les comparaisons simultanées permettent au commutateur de réseau d'effectuer des commutations de niveau 3 pour des réseaux de 100 Mbps et 100 Go sans blocage du commutateur de réseau.
Patent EP-1265574-A2 (EP)
Inventor: AHR NICHOLAS ALBERT
IPC: A61F13/49
Filed: 2001-01-10
Abstract: A disposable absorbent article having an expandable component. The expandable component can be inflatable, and includes a gas evolving material and an activating material separated from the gas evolving material by a breakable barrier. The barrier is broken to combine the materials and inflate the component at the point of use of the disposable absorbent article. The inflatable component can include a spacer for maintaining a fecal void space in a disposable absorbent article.
Patent EP-1294750-A2 (EP)
Title: Composition de proteine arabinogalactane modifiee par un acide
Inventor: AN JINHUA
IPC: A61P31/04
Filed: 2001-06-28
Abstract: La présente invention concerne une composition de protéine arabinogalactane modifiée par un acide dans laquelle le rapport arabinose-galactose est inférieur à 3,5 : 1 ou inférieur à 80 % du rapport arabinose : galactose du constituant de protéine arabinogalactane de la composition avant la modification par un acide. Cette composition est préparée à partir de Astragalus membranaceus, plus particulièrement à partir des racines de Atragalus membranaceus, elle peut être reconstituée pour former une formulation aqueuse injectable par voie intraveineuse et elle est utile pour stimuler l'hématopoïèse, induire la prolifération ou la maturation des mégacaryocytes, stimuler la production de IL-1ß, Il-6, TNF-α, IFN-η, GM-CSF, ou G-CSF, stimuler la production ou l'action des neutrophiles, traiter la neutropénie, l'anémie ou la thrombocytopénie, accélérer le rétablissement suite à l'exposition (qu'elle soit de nature accidentelle ou non thérapeutique ou bien de nature thérapeutique) à des agents cytotoxiques ou à des rayonnements, traiter la cachexie, les vomissements ou les symptômes de sevrage de drogue, ou modifier les réponses biologiques ou protéger les cellules hépatiques en cas d'hépatite B, chez un mammifère lorsqu'on lui a injecté par voie intraveineuse ladite formulation.
Patent EP-1370196-A2 (EP)
Inventor: OBERLE HEINZ
IPC: A61F2/848
Filed: 2001-05-31
Abstract: Die vorliegende Erfindung betrifft einen Stent, welcher aus einem ersten Zustand mit geringer lichter Weite in einen zweiten Zustand expandierbar ist, in welchem die lichte Weite vergrößert ist, und materialfreie Bereiche an Materialstege grenzen, um mit diesen einen allgemeine Stentmantelfläche zu definieren über welche Materialstege abschnittsweise im expandierten Zustand ragen. Hierbei ist vorgesehen, daß eine erste Gruppe von Abschnitten dazu vorgesehen ist, im implantierten Zustand in Flußrichtung über die Stentmantelfläche überzuragen und eine zweite Gruppe von Abschnitten dazu vorgesehen ist, im implantierten Zustand in Gegenflußrichtung über die Stentmantelfläche überzuragen.